Status: Recruiting
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ID110521156 in Healthy Adult Subjects
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple oral doses of ID110521156 in healthy adult subjects.
Participants needed: 36
Trial details
Phase: Phase 1Age: 19-50Biological sex: AllType: InterventionalSponsor: IlDong Pharmaceutical Co LtdUpdated: Dec 24, 2024Locations: 1
Eligibility criteria
Healthy subjects aged 19 to 50 years at the time of Screening. [+3]
Evidence or history of clinically significant hepatic, renal, neurological, immu... [+2]